Neurocrine Biosciences Announces New Survey Results Showing Significant Burden of Tardive Dyskinesia on Employment
Go back to Neurocrine Biosciences Announces New Survey Results Showing Significant Burden of Tardive Dyskinesia on Employment| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 161.44 -0.18 (0.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $161.62 | 52 Week High | $58.46 | |||
| Open | $161.62 | 52 Week Low | $31.25 | |||
| Day High | $163.53 | P/E | N/A | |||
| Day Low | $160.42 | EPS | $-0.69 | |||
| Volume | 1,076,139 | |||||
